Back

EMPOWER Study

Official Title

An observational, non-interventional, study of patients with Hereditary Angioedema in the United States and Canada (EMPOWER Study)

Study Details

The purpose of the study is to look at the effectiveness of lanadelumab in preventing HAE (Hereditary Angioedema) attacks . It will also examine the quality of life and the use of healthcare resources for HAE attacks before and after lanadelumab treatment.

Principal Investigator

Dr. H. James Wedner

IRB Number

201904067

Eligibility

1. Participants must have diagnosis of HAE Type I or Type II
2. Participants must have the ability to use a mobile device for data collection in the study

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back